To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.

Sponsor: Earl L. "Buddy" Carter (Republican-GA)February 12, 2026

AI-generated ?

Report an error

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Referred to the House Committee on Energy and Commerce.

Lets specialized drug facilities keep supplying medicines for 6 months after shortages end

This bill would let specialized drug facilities continue to make and send out medicines for up to 180 days after a drug is no longer officially in shortage. This change aims to prevent new shortages and help patients get the medicines they need more consistently. It would give these facilities more flexibility to keep drug supplies steady.

What Would Change

Today, specialized drug facilities must stop supplying a drug as soon as it's no longer officially in shortage. If this bill becomes law, these facilities could keep supplying that drug for up to 180 calendar days after the official shortage ends.

Key Provisions

Extends the time specialized drug facilities can supply drugs that were in shortage to 180 days after the shortage officially ends.

View on Congress.gov

HR 7528 · 119th Congress · February 12, 2026 · AI Summary by gemini-2.5-flash · 10/10

To amend section 503B of the Federal Food, Drug, and Cosmetic Act to enhance the ability of outsourcing facilities to mitigate drug shortages by allowing a short-term period to continue supplying the market after a drug is in shortage.

What Would Change

Key Provisions

Lobbying Activity